LORI HINNANT and KEN MORITSUGU / The Associated PressMar 3, 2020
Mushrooming outbreaks in other parts of the world contrast with optimism in China, where the number of new infections is dropping. Dig deeper ( 4 Min. Read )
Caroline Chen, Marshall Allen, Lexi Churchill and Isaac Arnsdorf / ProPublicaMar 2, 2020
The agency designed a flawed test for COVID-19, then took weeks to find a fix for state and local labs. The consequences could be deadly. Dig deeper ( 7 Min. Read )
ADAM GELLER, PAUL WISEMAN and CHRISTOPHER RUGABER / The Associated PressFeb 28, 2020
The list of countries touched by the illness climbs to nearly 60 as more than 83,000 people worldwide fall ill. Over 2,800 have died so far. Dig deeper ( 5 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
MATTHEW PERRONE / The Associated PressDec 13, 2019
The agency's OK, four months after it rejected the drug over safety concerns, may stoke questions about standards for clearing medications. Dig deeper ( 2 Min. Read )
MATTHEW PERRONE / The Associated PressMar 5, 2019
A medication related to the club drug Special K wins U.S. approval for patients with the hard-to-treat mood disorder. Dig deeper ( 4 Min. Read )
LINDSEY TANNER / The Associated PressJan 8, 2019
Doctors, industry clash on benefits of advertising drugs, devices, lab tests and hospitals directly to consumers. Dig deeper ( 3 Min. Read )
By Elizabeth Shogren and Susie Neilson / RevealSep 29, 2018
Congress ordered a fix to a gaping hole in food safety years ago, but the administration postponed a remedy that could prevent outbreaks. Dig deeper ( 10 Min. Read )
MATTHEW PERRONE / The Associated PressJun 25, 2018
Epidiolex, used to treat rare forms of epilepsy, contains CBD, a chemical ingredient found in the cannabis plant. FDA approval takes place in an increasingly complicated legal environment for marijuana. Dig deeper ( 4 Min. Read )
LINDSEY TANNER / The Associated PressMay 8, 2018
The Journal of the American Medical Association focuses on for-profit clinics that advertise costly, unproven stem-cell treatments for a variety of conditions, often marketing them as cures or promising vastly improved health. Dig deeper ( 4 Min. Read )
MATTHEW PERRONE / The Associated PressApr 17, 2018
The medication, which doesn’t get users high, reduces rare, hard-to-treat seizures in children. It could be in line to be the first U.S. government-approved drug derived from the cannabis plant. Dig deeper ( 3 Min. Read )
LINDSEY TANNER / The Associated PressFeb 14, 2018
The procedure doesn't detect concussions, but it could help open the door to advances in this crucial area of diagnostic medicine. Dig deeper ( 3 Min. Read )
Eileen Cronin / TruthdigFeb 23, 2017
The next DNC chair has an important job: protect the rights of citizens and stand up for the rule of law. Dig deeper ( 4 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, please login or create a user profile.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, upgrade to supporter.